Hazlett, Burt & Watson’s Dynavax Technologies DVAX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-700
| Closed | -$11K | – | 927 |
|
|
2025
Q4 | $11K | Hold |
700
| – | – | ﹤0.01% | 689 |
|
|
2025
Q3 | $7K | Hold |
700
| – | – | ﹤0.01% | 698 |
|
|
2025
Q2 | $7K | Hold |
700
| – | – | ﹤0.01% | 631 |
|
|
2025
Q1 | $9K | Hold |
700
| – | – | ﹤0.01% | 582 |
|
|
2024
Q4 | $9K | Hold |
700
| – | – | ﹤0.01% | 555 |
|
|
2024
Q3 | $8K | Hold |
700
| – | – | ﹤0.01% | 549 |
|
|
2024
Q2 | $8K | Hold |
700
| – | – | ﹤0.01% | 537 |
|
|
2024
Q1 | $9K | Hold |
700
| – | – | 0.01% | 521 |
|
|
2023
Q4 | $10K | Hold |
700
| – | – | 0.01% | 493 |
|
|
2023
Q3 | $10K | Hold |
700
| – | – | 0.01% | 497 |
|
|
2023
Q2 | $9K | Hold |
700
| – | – | 0.01% | 483 |
|
|
2023
Q1 | $7K | Hold |
700
| – | – | 0.01% | 483 |
|
|
2022
Q4 | $7K | Hold |
700
| – | – | 0.01% | 492 |
|
|
2022
Q3 | $7K | Hold |
700
| – | – | 0.01% | 485 |
|
|
2022
Q2 | $9K | Hold |
700
| – | – | 0.01% | 466 |
|
|
2022
Q1 | $8K | Buy |
+700
| New | +$8.5K | 0.01% | 484 |
|
Other funds holding DVAX
Hazlett, Burt & Watson's DVAX Position: Q1 2026 in Review
Hazlett, Burt & Watson sold out of Dynavax Technologies (DVAX) in Q1 2026, closing a stake of 700 shares — an estimated $11K sold.
Hazlett, Burt & Watson first reported a position in DVAX in Q1 2022 and held it in 16 quarters. The position peaked at $11K in Q4 2025. 1 fund tracked by Wall St. Rank holds DVAX as of Q1 2026.
- Hazlett, Burt & Watson reported no remaining Dynavax Technologies position as of Q1 2026 after selling out during the quarter.
- Hazlett, Burt & Watson sold 700 Dynavax Technologies shares in Q1 2026, an estimated $11K.
- Hazlett, Burt & Watson first reported a position in Dynavax Technologies in Q1 2022 and held it in 16 quarters.
- Hazlett, Burt & Watson's Dynavax Technologies position peaked at $11K in Q4 2025.
- 1 fund tracked by Wall St. Rank held Dynavax Technologies as of Q1 2026.
Based on Hazlett, Burt & Watson's 13F filing for Q1 2026, filed 14 May 2026.